Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy?

Angeles Rovirosa; Faegheh Noorian; Sofia Cordoba; Francesc León; Valentina Lancellotta; Luca Tagliaferri; Antonio Herrreros

doi:10.5114/jcb.2024.144183

eISSN: 2081-2841
ISSN: 1689-832X

Journal of Contemporary Brachytherapy

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

Send email

Copy url:

abstract:

Original paper

Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy?

Angeles Rovirosa

^{1, 2, 3}

,

Faegheh Noorian

^{1, 2}

,

Sofia Cordoba

⁴

,

Francesc León

²

,

Valentina Lancellotta

⁵

,

Luca Tagliaferri

⁵

,

Antonio Herrreros

^{1, 2}

Fonaments Clinics Department, Universitat de Barcelona, Barcelona, Spain
Radiation Oncology Department, Hospital Clínic-Universitat de Barcelona, IDIBAPS, Barcelona, Spain
Gynecological Cancer Unit, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
Radiation Oncology Department, Hospital Puerta de Hierro, Madrid, Spain
U.O.C. Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy

J Contemp Brachytherapy 2024; 16, 5

DOI: https://doi.org/10.5114/jcb.2024.144183

Online publish date: 2024/10/16

View full text Get citation

Purpose:
Currently, there are many schedules for exclusive vaginal cuff brachytherapy (VCB). In 3D treatment planning for VCB dosimetry, parameters have not been analyzed. The aim of this study was to compare the most common schedules using dose-volume histogram metrics.

Material and methods:
Three different computed tomography (CT) studies for vaginal cylinders of 3.5 cm, 3 cm, and 2.5 cm were performed. Clinical target volume (CTV) was delineated for 3 cm and 4 cm of vaginal length. Twelve schedules were analyzed obtaining overall vaginal surface dose (Gy) (EQD₂ α/β = 10 and α/β = 3), overall D₉₀ CTV _{(α/β = 10)} (Gy), and overall D_{2cc (α/β = 3)} for organs at risk (OARs), such as vagina, rectum, sigmoid, rectum, and bladder. Prescription at 5 mm from the applicator surface and at the surface were analyzed for each case.

Results:
The overall vaginal surface dose and dose to CTV varied widely among the different schedules, and CTV delineation was necessary in case of surface prescription. The applicator diameter of 3.5 cm showed the best dosimetry results for vaginal surface dose. The overall D_2cc OARs’ doses changed in the different CT studies.

Conclusions:
This dosimetry study allows for better selection of fractionation schedules, and helps to unify treatments among centers. Prospective studies are needed to establish the best schedule and CTV length in each patient using clinical data, such as late toxicity and relapses.

keywords:

Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy?

Angeles Rovirosa 1, 2, 3 , Faegheh Noorian 1, 2 , Sofia Cordoba 4 , Francesc León 2 , Valentina Lancellotta 5 , Luca Tagliaferri 5 , Antonio Herrreros 1, 2

vaginal-cuff brachytherapy, endometrial cancer, schedules

Angeles Rovirosa

^{1, 2, 3}

,

Faegheh Noorian

^{1, 2}

,

Sofia Cordoba

⁴

,

Francesc León

²

,

Valentina Lancellotta

⁵

,

Luca Tagliaferri

⁵

,

Antonio Herrreros

^{1, 2}